Ant's Rant - The First of Many
There’s been a lot of hot air blowing around lately about Bill Gates’s decision to invest $10M in our friends at Schrodinger. Some have even suggested that this might mean a return to the heady days of...
View ArticleThe Rant Goes On…
In August, I gave a talk at the Boston ACS meeting about the contribution of academics to molecular modeling. Okay, their lack of contribution to molecular modeling. I might even have had a slide that...
View ArticleCloud Computing
I am frequently being asked by our users whether OpenEye's licensing model allows them to run OpenEye software in the cloud. As this appears to be a common concern and a potential legal stumbling block...
View ArticleThe Bayh-Dole Act
In my last post, I ranted on about the problems surrounding contributions by academics to molecular modeling, and cited as a particular issue the Bayh-Dole Act (BD), which enabled and encouraged...
View ArticleRecommendation System for Compound Selection
Just recently, Swann et al. of Abbott Labs published "A Unified, Probabilistic Framework for Structure- and Ligand-Based Virtual Screening" in the Journal of Medicinal Chemistry. If you haven’t read it...
View ArticleWhat Is Really Killing Pharma
Sometimes it’s frustrating being in the business of servicing an industry so manifestly important and so manifestly stupid. I started OpenEye to help those I had come to know in pharma do a better job,...
View ArticleCuring Pharma: (1) Avoiding Hype-based Science
I’ve been thinking a lot lately about Jacques Tati’s masterful 1967 work Play Time, which describes an antiseptic, colorless and angular world of the future, a bleak world that only relents when the...
View ArticleOn the Passing of Andrew Grant
Of the many reasons to restart my blog I expected least the death of a friend. As many of you know, Andrew Grant of AstraZeneca and long-time OpenEye collaborator, passed away on the 29th of December....
View ArticleA Different Conference
http://www.grc.org/programs.aspx?year=2013&program=caddread more
View ArticleCD and MD
When the recent Nobel Prize for Chemistry was announced, going to Karplus, Levitt and Warshel I assumed it must have been for “Services to Molecular Dynamics”. As such, I joined the debate on Derek...
View Article
More Pages to Explore .....